Skip to main content

Table 2 Chemo susceptibility of TUBO and TUBO-P2J cells

From: Intratumoral heterogeneity impacts the response to anti-neu antibody therapy

Chemoreagent

IC50

TUBO

TUBO-P2J

Carboplatin

0.22 mg/ml

4.97 mg/ml

Cisplatin

4.2 ug/ml

3.53 ug/ml

Cyclophosphamide

0.15 mg/ml

1.93 mg/ml

Daunorubicin

UD

326 ng/ml

Doxoruibicin

56.9 ng/ml

306.6 ng/ml

Epirubicin

2.87 ng/ml

40.3 ng/ml

Etoposide

84 ug/ml

76.63 ug/ml

Gemcitabin

0.55 ng/ml

6.4 ng/ml

Idarubicin

UD

0.98 ug/ml

Irinotecan

1.7 mg/ml

0.95 mg/ml

Oxaliplatin

0.26 ug/ml

34.55 ug/ml

Vinorelbine

0.23 ug/ml

6.8 ug/ml

  1. UD under detected.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us